STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1675 by analyst upside · 2026-06-27
EHC
Encompass Health Corporation
Healthcare · Market Cap $10B · P/E 17.1x
ANALYST PRICE TARGET
+38.7%
implied upside to consensus target
Current Price $101.33
Consensus Target $140.5
Bull Target $152.0
Bear Target $125.0
Analysts Covering 12
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
11
Hold
0
Sell
0
52-Week Low $92.77
52-Week High $127.99
YTD Return -4.6%
FUNDAMENTALS
Market Cap $10B
P/E Ratio (TTM) 17.1x
Forward P/E 15.5x
EPS (TTM) $5.94
PEG Ratio 0.41
Dividend Yield 0.75%
Revenue (TTM) $6.1B
Profit Margin 10.0%
52-WEEK RANGE
52-Week Low $92.77
52-Week High $127.99
Current Price $101.33
Bear Target $125.0
Bull Target $152.0
● Now $101.33 ● Target $140.5
TRADING DATA
Avg Volume 988K
YTD Return -4.6%
Analyst Count 12
Consensus Buy
Upside to Target +38.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Encompass Health Corporation (EHC) is currently trading at $101.33 with a Wall Street consensus price target of $140.5, implying potential upside of 38.7% over the next 12 months. 12 analysts currently cover EHC, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $152.0, while the most cautious has a target of $125.0.

EHC operates in the Healthcare sector with a market capitalisation of $10B. The stock is down 4.6% year-to-date and is currently trading near the lower end of its 52-week range of $92.77 – $127.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for EHC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen ● Initiated
Buy 2026-05-28 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-05-05 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-02-06 Building track record
Barclays — Reiterated
Overweight → Overweight 2025-10-30 Building track record
UBS — Reiterated
Buy → Buy 2025-10-02 33% win rate (6 calls)
Keybanc — Reiterated
Overweight → Overweight 2025-09-16 Building track record
B of A Securities — Reiterated
Buy → Buy 2025-09-10 Building track record
Truist Securities — Reiterated
Buy → Buy 2025-08-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →